# Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC.

> **NCT00295672** · PHASE2 · COMPLETED · sponsor: **University Hospital, Brest** · enrollment: 60 (estimated)

## Conditions studied

- Lung Neoplasm

## Interventions

- **DRUG:** Vinorelbine

## Key facts

- **NCT ID:** NCT00295672
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00295672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00295672, "Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00295672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*